183 related articles for article (PubMed ID: 33199785)
1. The value of MR-based radiomics in identifying residual disease in patients with carcinoma in situ after cervical conization.
Song M; Lin J; Song F; Wu D; Qian Z
Sci Rep; 2020 Nov; 10(1):19890. PubMed ID: 33199785
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of cervical intraepithelial neoplasia positive cutting edge after conization].
Dai ZQ; Pan LY; Huang HF
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):153-4. PubMed ID: 17645859
[No Abstract] [Full Text] [Related]
3. Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer.
Wong AS; Li WH; Cheung TH
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():21-6. PubMed ID: 26894378
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease.
Kalogirou D; Antoniou G; Karakitsos P; Botsis D; Kalogirou O; Giannikos L
Eur J Gynaecol Oncol; 1997; 18(2):113-6. PubMed ID: 9105859
[TBL] [Abstract][Full Text] [Related]
5. [Cervical carcinoma in situ: a clinical and pathological analysis of 118 cases].
Yang JX; Shen K; Lang JH; Huang HF; Wu M; Pan LY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):300-2. PubMed ID: 16677520
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
Hartman CA; Teixeira JC; Barbosa SB; Figueiredo SM; Andrade LA; Bastos JF
Int J Gynecol Cancer; 2017 Feb; 27(2):357-363. PubMed ID: 27984378
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
[TBL] [Abstract][Full Text] [Related]
9. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
11. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses.
Maluf PJ; Adad SJ; Murta EF
Tumori; 2004; 90(5):473-7. PubMed ID: 15656332
[TBL] [Abstract][Full Text] [Related]
12. Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
Lin H; Chang HY; Huang CC; Changchien CC
Int J Gynecol Cancer; 2004; 14(2):311-6. PubMed ID: 15086731
[TBL] [Abstract][Full Text] [Related]
13. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
14. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
15. [Predictors of residual lesion in cervix after conization in patients with cervical intraepithelial neoplasia and microinvasive cervical cancer].
Tan XJ; Wu M; Lang JH; Ma SQ; Shen K; Yang J
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):17-20. PubMed ID: 19489237
[TBL] [Abstract][Full Text] [Related]
16. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
17. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma.
Lee SW; Kim YM; Son WS; You HJ; Kim DY; Kim JH; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(2):209-15. PubMed ID: 19093236
[TBL] [Abstract][Full Text] [Related]
19. Residual and recurrent lesions after conization for cervical intraepithelial neoplasia grade 3.
Milojkovic M
Int J Gynaecol Obstet; 2002 Jan; 76(1):49-53. PubMed ID: 11818094
[TBL] [Abstract][Full Text] [Related]
20. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
